Healthcare

EU regulation creates post-approval challenge for healthcare AI

A healthcare AI analysis highlighted the continuing compliance burden for AI-enabled medical software under EU medical-device rules and the AI Act.

A healthcare AI analysis argued that regulatory approval is only the beginning of the implementation challenge. In the European Union, updates to AI-enabled medical software must be assessed against the Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation, with the EU AI Act also becoming relevant. This creates continuing compliance obligations as models, software components, and clinical functions change. The issue matters for healthcare companies because approval does not eliminate the need for post-market oversight, documentation, risk management, and regulatory reassessment. Organizations deploying AI therefore need processes that track model updates and preserve evidence that systems remain safe and compliant throughout their operational life.

Original source: MedCity News

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI